The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA5090410
PubChem CID: 166635032
Max Phase: Preclinical
Molecular Formula: C20H20N2O5
Molecular Weight: 368.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(C(=O)N2C3Cc4ccccc4C2CNC3=O)cc(OC)c1O
Standard InChI: InChI=1S/C20H20N2O5/c1-26-16-8-12(9-17(27-2)18(16)23)20(25)22-14-7-11-5-3-4-6-13(11)15(22)10-21-19(14)24/h3-6,8-9,14-15,23H,7,10H2,1-2H3,(H,21,24)
Standard InChI Key: JRZNNUGTWNEAQO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-2.0638 1.7805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3492 2.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6373 1.7809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6373 0.9557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3474 0.5439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0638 0.9520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0567 2.3615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7685 2.3615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3491 1.7809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3491 0.9557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7685 0.3751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0565 0.3751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0638 2.1935 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5113 1.4117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0074 0.4946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8323 0.4718 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5948 -0.2200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0072 -0.9348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5952 -1.6468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2301 -1.6468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6420 -0.9366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2338 -0.2200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0078 -2.3615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8330 -2.3615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6427 -2.3615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4672 -0.9366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8798 -1.6512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 1 0
9 8 1 0
10 9 1 0
11 10 1 0
12 11 1 0
4 12 1 0
9 13 2 0
8 14 1 0
12 14 1 0
14 15 1 0
15 16 2 0
15 17 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
22 21 2 0
17 22 1 0
19 23 1 0
23 24 1 0
20 25 1 0
21 26 1 0
26 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.39Molecular Weight (Monoisotopic): 368.1372AlogP: 1.65#Rotatable Bonds: 3Polar Surface Area: 88.10Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.36CX Basic pKa: ┄CX LogP: 1.41CX LogD: 1.37Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.86Np Likeness Score: 0.17
References 1. Winter-Holt JJ, Bardelle C, Chiarparin E, Dale IL, Davey PRJ, Davies NL, Denz C, Fillery SM, Guérot CM, Han F, Hughes SJ, Kulkarni M, Liu Z, Milbradt A, Moss TA, Niu H, Patel J, Rabow AA, Schimpl M, Shi J, Sun D, Yang D, Guichard S.. (2022) Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models., 65 (4.0): [PMID:35133824 ] [10.1021/acs.jmedchem.1c01871 ]